Cargando…

Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer

MicroRNAs are a class of naturally occurring small non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level and regulate complex patterns of gene expression. Our previous studies demonstrated that in human prostate cancer the miRNA miR-125b is highly expressed, leading to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amir, Sumaira, Ma, Ai-Hong, Shi, Xu-Bao, Xue, Lingru, Kung, Hsing-Jien, deVere White, Ralph W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621663/ https://www.ncbi.nlm.nih.gov/pubmed/23585871 http://dx.doi.org/10.1371/journal.pone.0061064

Ejemplares similares

Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
por: Suarez, Oscar J., et al.
Publicado: (2020)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression
por: Xie, Hua, et al.
Publicado: (2018)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

p14(ARF )expression in invasive breast cancers and ductal carcinoma in situ – relationships to p53 and Hdm2
por: Vestey, SB, et al.
Publicado: (2004)

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes
por: Kashuba, Elena, et al.
Publicado: (2003)

Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity
por: Cui, Long, et al.
Publicado: (2019)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14(ARF)-Mediated Sustained p53 Activation
por: Tomicic, Maja T., et al.
Publicado: (2021)

Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019)

p53 Amino-Terminus Region (1–125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype
por: Sharma, Anuj Kumar, et al.
Publicado: (2009)

Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
por: Xiaofang, Liu, et al.
Publicado: (2012)

Increased Arf/p53 activity in stem cells, aging and cancer
por: Carrasco‐Garcia, Estefania, et al.
Publicado: (2017)

p19( Arf) Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
por: Kelly-Spratt, Karen S, et al.
Publicado: (2004)

Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma
por: Chaar, Ines, et al.
Publicado: (2013)

LRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2017)

Farnesoid X receptor functions in cervical cancer via the p14(ARF)-mouse double minute 2-p53 pathway
por: Huang, Xiaohua, et al.
Publicado: (2022)

Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53
por: Eischen, Christine M., et al.
Publicado: (2012)

Regulation of p14(ARF )expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development
por: To, Kwong-Him, et al.
Publicado: (2012)

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2018)

The effects of fucodian on senescence are controlled by the p16(INK4a)-pRb and p14(Arf)-p53 pathways in hepatocellular carcinoma and hepatic cell lines
por: MIN, EUN-YOUNG, et al.
Publicado: (2014)

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022)

Human Papillomavirus 16 Oncoprotein E7 Stimulates UBF1-Mediated rDNA Gene Transcription, Inhibiting a p53-Independent Activity of p14(ARF)
por: Dichamp, Isabelle, et al.
Publicado: (2014)

Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
por: McDonald, A. C., et al.
Publicado: (1998)

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
por: Sonnemann, J, et al.
Publicado: (2014)

Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo
por: Kon, Ning, et al.
Publicado: (2019)

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
por: Chenlo, Miguel, et al.
Publicado: (2019)

Loss of miRNA biogenesis induces p19(Arf)-p53 signaling and senescence in primary cells
por: Mudhasani, Rajini, et al.
Publicado: (2008)

AKT regulates NPM dependent ARF localization and p53(mut) stability in tumors
por: Hamilton, Garth, et al.
Publicado: (2014)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

P14(ARF): The Absence that Makes the Difference
por: Cilluffo, Danilo, et al.
Publicado: (2020)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

Large-Scale Mutagenesis in p19(ARF)- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks
por: Uren, Anthony G., et al.
Publicado: (2008)

Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19(ARF)–p53 pathway
por: Nagao, Motoshi, et al.
Publicado: (2008)

Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19(ARF)–p53 pathway
por: Nagao, Motoshi, et al.
Publicado: (2009)

Loss of p19(Arf) Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms
por: Ulanet, Danielle B., et al.
Publicado: (2010)

The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
por: Wagner, Kay-Dietrich, et al.
Publicado: (2022)

P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance
por: Hashimoto, Ari, et al.
Publicado: (2016)

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53
por: Fry, Elizabeth A., et al.
Publicado: (2020)

p53- and p73-independent activation of TIGAR expression in vivo
por: Lee, P, et al.
Publicado: (2015)

p21 can be a barrier to ferroptosis independent of p53
por: Venkatesh, Divya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ijs3dj6kf3aqe6h5nnblhk3c6g